profit from every $100 of sales.
$0$100
PetMed Express
$0.94-4.96% today
-52.0% in 1 year
1-year low $0.941-year high $3.90
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2026.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What PetMed Express sold, what it kept, and what it did with the cash.
Sales went from $272 million in 2022 to $179 million in 2026, with -$57.3 million of profit last year.
SalesProfit
PetMed Express vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| PetMed Express | No profit yet | ||
 Atai Beckley N.V | No profit yet | ||
 Avalyn Pharma | No profit yet | ||
 Cullinan Therapeutics | No profit yet | ||
 High Tide | No profit yet |
AI analysis
An AI analyst reads PetMed Express's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|
| 272 | 248 | 274 | 179 | |
| 77 | 77 | 85 | 50 | |
| 24 | 6 | -8 | -31 | |
| 27 | 10 | -1 | -22 | |
| 19 | 5 | -7 | -57 | |
| – | 0.01 | -0.37 | -2.74 | |
| 28.3% | 30.9% | 30.9% | 28.1% | |
| 8.9% | 2.4% | -3.0% | -17.5% | |
| 6.9% | 2.1% | -2.7% | -32.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|
| Total assets | 180 | 167 | 170 | 81 |
| Cash | 111 | 104 | 55 | 21 |
| Total debt | – | 0 | 1 | 1 |
| Total liabilities | 56 | 58 | 73 | 52 |
| 123 | 110 | 97 | 29 | |
| – | 20 | 20 | 21 | |
| 15.5% | 4.3% | -6.6% | -84.2% | |
| 15.2% | 4.7% | -7.7% | -197.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|
| 18 | 28 | 4 | -28 | |
| 2 | 5 | 5 | 5 | |
| 17 | 23 | -0 | -33 | |
| Dividends paid | 24 | 25 | 12 | 0 |
| 0 | – | – | – | |
| 5 | 7 | 7 | 1 |
Valuation
- –
- 13.4×
- –
- 1.5×
- 0.1×
- –
- –
- -157.9%
- -274.1%
- 0.0%
Profitability
- 28.1%
- -17.5%
- -32.0%
- -26.5%
- -94.2%
- 4.3%
- -122.1%
- -73.7%
- -95.6%
- –
Growth
- −10.0%
- –
- −103.6%
- −2.9%
- +0.7%
Financial health
- -0.9×
- 0.02
- 0.7%
- -74.5×
- 0.89
- 0.66
- 2.08
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 1%of 952
Bottom 13%of 884
Bottom 8%of 886
What analysts expect
- Average price target
- $11.00
- Range
- $7.00 – $19.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Feb 5, 2026 | -0.50 | -0.06 | −733.3% |
| Dec 19, 2025 | -0.34 | -0.02 | −1,600.0% |
| Feb 10, 2025 | -0.03 | 0.01 | −700.0% |
| Nov 6, 2024 | 0.11 | -0.05 | +320.0% |
| Aug 6, 2024 | 0.18 | -0.09 | +300.0% |
| Apr 15, 2024 | -0.10 | -0.01 | −900.0% |
| Feb 8, 2024 | -0.10 | -0.01 | −900.0% |
| Oct 30, 2023 | -0.00 | 0.09 | −103.8% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
30No pass
Benjamin Graham
47No pass
Philip Fisher
31No pass
Peter Lynch
28No pass
Joel Greenblatt
0No pass
Charlie Munger
25No pass
Terry Smith
14No pass
Questions about PetMed Express
Is PetMed Express a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the PetMed Express AI analysis
What does PetMed Express do?
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It is in Medical - Pharmaceuticals.
Does PetMed Express pay a dividend?
Yes. In 2026 it paid out $21,000 in dividends.
Is PetMed Express stock halal?
No. PetMed Express does not pass our halal screen: its cash and confirmed interest-bearing investments are 102% of its market value, at or above the 33% limit. How we check
How has PetMed Express stock done over the past year?
Down 52.0% over the past twelve months, to $0.94. It traded between $0.94 and $3.90 and is 75.9% below its high.
Who are PetMed Express's competitors?
The largest listed companies in the same industry are Atai Beckley N.V, Avalyn Pharma, Cullinan Therapeutics and High Tide. The peers table on this page compares their profit, growth and price with PetMed Express's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.